Next Chapter In The Amylin Chronicles: Job Cuts, Restructuring

Troubled by slower Byetta growth and uncertainty around the development of a long-acting version, Amylin will cut 25 percent of its San Diego workforce.

More from Archive

More from Pink Sheet